SRDX - Surmodics, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Eden Prairie,
United States
Type: Equity
SRDX price evolution
SRDX
| (in millions $) | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $19 | $20.07 | $24.71 | |
| Short term investments | $2.01 | $2.01 | ||
| Net receivables | $10.45 | $9.38 | $11.04 | |
| Inventory | $11.82 | $10.93 | $9.47 | |
| Total current assets | $57.59 | $60.03 | $64.68 | |
| Long term investments | ||||
| Property, plant & equipment | $27.15 | $28.29 | $29.08 | |
| Goodwill & intangible assets | $68.86 | $73.34 | $77.76 | |
| Total noncurrent assets | $100.77 | $115.62 | $119.51 | |
| Total investments | $2.01 | $2.01 | ||
| Total assets | $158.36 | $175.65 | $184.19 | |
| Current liabilities | ||||
| Accounts payable | $3.14 | $1.93 | $2.11 | |
| Deferred revenue | $9.25 | $11.41 | $12.44 | |
| Short long term debt | $10 | $10 | $10 | |
| Total current liabilities | $32.08 | $29.39 | $28.37 | |
| Long term debt | ||||
| Total noncurrent liabilities | $17.89 | $21.15 | $22.55 | |
| Total debt | $10 | $10 | $10 | |
| Total liabilities | $49.97 | $50.54 | $50.92 | |
| Shareholders' equity | ||||
| Retained earnings | $88.79 | $103.52 | $109.17 | |
| Other shareholder equity | -$9.87 | -$5.72 | -$1.43 | |
| Total shareholder equity | $108.39 | $125.11 | $133.26 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $19 | $31.15 | $30.79 | $30.36 |
| Short term investments | $7.72 | $30.31 | $24.93 | |
| Net receivables | $10.45 | $9.17 | $7.67 | $8.99 |
| Inventory | $11.82 | $6.76 | $5.97 | $4.5 |
| Total current assets | $57.59 | $70.25 | $86.61 | $81.42 |
| Long term investments | $2 | |||
| Property, plant & equipment | $27.15 | $30.09 | $30.1 | $29.75 |
| Goodwill & intangible assets | $68.86 | $82.66 | $40.47 | $40.4 |
| Total noncurrent assets | $100.77 | $124.34 | $82.16 | $78.44 |
| Total investments | $9.72 | $30.31 | $24.93 | |
| Total assets | $158.36 | $194.59 | $168.76 | $159.87 |
| Current liabilities | ||||
| Accounts payable | $3.14 | $1.78 | $1.51 | $2.08 |
| Deferred revenue | $9.25 | $14.95 | $16 | $17.18 |
| Short long term debt | $10 | $10 | ||
| Total current liabilities | $32.08 | $29.82 | $18.89 | $20.21 |
| Long term debt | ||||
| Total noncurrent liabilities | $17.89 | $24.69 | $18.82 | $17.14 |
| Total debt | $10 | $10 | ||
| Total liabilities | $49.97 | $54.51 | $37.71 | $37.35 |
| Shareholders' equity | ||||
| Retained earnings | $88.79 | $116.06 | $111.83 | $110.7 |
| Other shareholder equity | -$9.87 | $1.73 | $3.17 | $0.4 |
| Total shareholder equity | $108.39 | $140.09 | $131.06 | $122.52 |
| (in millions $) | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $25.99 | $24.85 | $26.11 | |
| Cost of revenue | $5.6 | $5.14 | $5.11 | |
| Gross Profit | $20.39 | $19.71 | $21 | |
| Operating activities | ||||
| Research & development | $12.26 | $12.97 | $13.71 | |
| Selling, general & administrative | $13.78 | $12.85 | $11.11 | |
| Total operating expenses | $27.18 | $26.89 | $25.9 | |
| Operating income | -$6.79 | -$7.18 | -$4.9 | |
| Income from continuing operations | ||||
| EBIT | -$6.6 | -$7.04 | -$4.87 | |
| Income tax expense | $7.94 | -$1.53 | -$0.92 | |
| Interest expense | $0.19 | $0.14 | $0.13 | |
| Net income | ||||
| Net income | -$14.73 | -$5.65 | -$4.08 | |
| Income (for common shares) | -$14.73 | -$5.65 | -$4.08 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $99.95 | $105.14 | $94.86 | $100.08 |
| Cost of revenue | $20.34 | $17.18 | $15.32 | $13.64 |
| Gross Profit | $79.61 | $87.96 | $79.55 | $86.44 |
| Operating activities | ||||
| Research & development | $50.61 | $46.73 | $50.19 | $52.88 |
| Selling, general & administrative | $46.94 | $30.68 | $28.39 | $23.95 |
| Total operating expenses | $102.1 | $81.26 | $80.8 | $79.97 |
| Operating income | -$22.49 | $6.7 | -$1.25 | $6.47 |
| Income from continuing operations | ||||
| EBIT | -$21.89 | $6.66 | -$1.32 | $7.71 |
| Income tax expense | $4.78 | $2.11 | -$2.58 | -$0.03 |
| Interest expense | $0.6 | $0.31 | $0.13 | $0.15 |
| Net income | ||||
| Net income | -$27.27 | $4.24 | $1.12 | $7.59 |
| Income (for common shares) | -$27.27 | $4.24 | $1.12 | $7.59 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$14.73 | -$5.65 | -$4.08 | -$2.81 |
| Operating activities | ||||
| Depreciation | $2.4 | $2.37 | $2.44 | $2.47 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.86 | $1.8 | $1.72 | $1.68 |
| Total cash flows from operations | -$2.5 | -$3.5 | -$4.2 | -$7.03 |
| Investing activities | ||||
| Capital expenditures | -$0.57 | -$0.86 | -$1.16 | -$0.78 |
| Investments | $2 | $3.6 | $4 | |
| Total cash flows from investing | $1.43 | -$0.86 | $2.44 | $3.22 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.48 | $0.02 | $0.51 | $0.23 |
| Net borrowings | ||||
| Total cash flows from financing | $0.3 | -$0.01 | -$0.04 | -$0.62 |
| Effect of exchange rate | -$0.3 | -$0.27 | -$0.15 | -$0.07 |
| Change in cash and equivalents | -$1.08 | -$4.64 | -$1.94 | -$4.5 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$27.27 | $4.24 | $1.12 | $7.59 |
| Operating activities | ||||
| Depreciation | $9.67 | $8.32 | $7.51 | $7.31 |
| Business acquisitions & disposals | -$40.55 | -$0.75 | ||
| Stock-based compensation | $7.06 | $5.86 | $5.45 | $5.08 |
| Total cash flows from operations | -$17.22 | $15.39 | $14.01 | $8.04 |
| Investing activities | ||||
| Capital expenditures | -$3.37 | -$5.28 | -$3.67 | -$5.99 |
| Investments | $9.6 | $20.59 | -$5.39 | $16.49 |
| Total cash flows from investing | $6.23 | -$25.24 | -$9.07 | $9.75 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.25 | $3.13 | $1.61 | $0.72 |
| Net borrowings | $10 | -$0.14 | ||
| Total cash flows from financing | -$0.38 | $10.23 | -$4.65 | -$11.03 |
| Effect of exchange rate | -$0.79 | -$0.01 | $0.13 | -$0.07 |
| Change in cash and equivalents | -$12.15 | $0.37 | $0.42 | $6.69 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.46 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |